Conference on Dynamics of Cholinergic Function: Overview and Comments

  • A. G. Karczmar
Part of the Advances in Behavioral Biology book series (ABBI, volume 30)


With each successive International Cholinergic Meeting its program increases and so do the logistic and fiscal problems. For this, the Fifth Meeting, these problems were particularly difficult to resolve, as the interest in the cholinergic system and the desire to participate were never so high, yet the state of the world’s economy made the financing of the Meeting particularly difficult.


Muscarinic Receptor Nicotinic Receptor Cholinergic Neuron Vasoactive Intestinal Polypeptide Choline Uptake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abdel-Latif, A.A., Akhtar, R.A. and Hawthorne, J.W. (1977): Biochem. J. 162: 61–73.Google Scholar
  2. 2.
    Abou-Donia, M.D., Graham, D.G. and Komcil, A.A. (1979): Toxicol. Appl. Pharmacol. 49: 293–299.Google Scholar
  3. 3.
    Akaike, A., Ikeda, S.R., Brookes, N., Pascuzzo, G., Rickett, D.L. and Albuquerque, E.X. (1984): Molec. Pharmacol. 25: 102–112.Google Scholar
  4. 4.
    Akasu, T., Karczmar, A.G. and Koketsu, K. (1983): Eur. J. Pharmacol. 88: 63–70.CrossRefGoogle Scholar
  5. 5.
    Albuquerque, E.X., Aguayo, L.G., Warnick, J.E., Weinstein, H., Glick, S.D., Maayani, S., Ickowicz, R.K. and Blanstein, M.D. (1981): Proc. U.S.A. Natl. Acad. Sci. 78: 7792–7796.Google Scholar
  6. 6.
    Albuquerque, E.X., Akaike, A., Shaw, K.-P. and Rickett, D.L. (1984): Fund. Appl. Toxicol. 4: 527 - S33.CrossRefGoogle Scholar
  7. 7.
    Aldridge, W.N. (1954): Chem. and Ind. 473–476.Google Scholar
  8. 8.
    Ansell, G.B. and Spanner, S. (1981): In: Cholinergic Mechanisms (eds) G. Pepeu and H. Ladinsky, Plenum Press, New York, pp. 393–403.Google Scholar
  9. 9.
    Ansell, G.B. and Spanner, S. (1982): In: Phospholipids in the Nervous System (eds) L.A. Horrocks, G.B. Ansell and G. Porcellatti, Raven Press, New York, 1: 137–144.Google Scholar
  10. 10.
    Bartus, R.T., Dean, R.L., Goas, J.A. and Lippa, S.A. (1980): Science 209: 301–309.CrossRefGoogle Scholar
  11. 11.
    Birdsall, M.J.M. and Hulme, E.L. (1976): J. Neurochem. 27: 7–16.CrossRefGoogle Scholar
  12. 12.
    Blusztajn, J.K. and Wurtman, R.J. (1983): Science 221: 614–620.CrossRefGoogle Scholar
  13. 13.
    Burn, J.H. and Rand, M.J. (1959): Nature 184: 163–165.CrossRefGoogle Scholar
  14. 14.
    Carlton, P.L. (1968): In: Psychopharmacology–A Review of Progress 1957–1967 (ed) D.H. Efron, U.S. Govt. Printing Office, PHS Publ. No. 836, Washington, D.C., pp. 125–135.Google Scholar
  15. 15.
    Carlton, P.L. (1968): Prog. Brain Res. 24: 48–60.CrossRefGoogle Scholar
  16. 16.
    Carnap, R. (1937): The Logical Syntax of Language, Harcourt, New York.Google Scholar
  17. 17.
    Costa, E., Chuang, D.M., Guidotti, A. and Hollenbeck, R. (1978): In: Cholinergic Mechanisms and Psychopharmacology (ed) D.J. Jenden, Plenum Press, New York, pp. 267–284.Google Scholar
  18. 18.
    Davis, B.M. and Davis, K.L. (1979): In: Brain Acetylcholine and Neuropsychiatric Disease (eds) K.L. Davis and P.A. Berger, Plenum Press, New York, pp. 445–458.Google Scholar
  19. 19.
    Dettbarn, W-D. (1984): Fund. Appl. Toxicol. 4: S18 - S26.CrossRefGoogle Scholar
  20. 20.
    DeRobertis, E. (1967): Science 156: 907–914.CrossRefGoogle Scholar
  21. 21.
    Drachman, D.A. (1978): In: Psychopharmacology: A Generation of Progress (eds) M.A. Lipton, A. DiMascio and K.F. Killam, Raven Press, New York, pp. 651–662.Google Scholar
  22. 22.
    Dun, N.J., Kaibara, K. and Karczmar, A.G. (1978): Brain Res. 150: 658–661.CrossRefGoogle Scholar
  23. 23.
    Dun, N.J. and Karczmar, A.G. (1978): Proc. Natl. Sci. U.S.A. 75: 4029–4032.Google Scholar
  24. 24.
    Dun, N.J. and Minota, S. (1981): J. Physiol. ( Lond. ) 321: 259–271.Google Scholar
  25. 25.
    Dun, N.J. and Karczmar, A.G. (1985): In: Vertebrate Autonomic and Enteric Ganglia: Anatomy. Electrophysiology and Neuropharma cology (eds) A.G. Karczmar, K. Koketsu and S. Nishi, Plenum Press, New York (in press).Google Scholar
  26. 26.
    Eccles, J.C., Fatt, P. and Koketsu, K. (1954): J. Physiol. ( Lond. ) 126: 524–562.Google Scholar
  27. 27.
    Eldefrawi, M.E., Eldefrawi, A.T., Mansour, N.A., Daly, J.W., Witkop, B. and Albuquerque, E.X. (1978): Biochemistry 17:5474–5484.Google Scholar
  28. 28.
    Fibiger, H.C. (1982): Brain Res. Rev. 4: 327–388.CrossRefGoogle Scholar
  29. 29.
    Fisher, A. and Hanin, I. (1980): Life Sci. 27: 1615–1634.CrossRefGoogle Scholar
  30. 30.
    Fonnum, F. and Sterri, S.H. (1981): Fund. Appl. Toxicol. 1: 143147.Google Scholar
  31. 31.
    Gallagher, J.P. and Karczmar, A.G. (1973): Neuropharmacol. 12: 783–792.CrossRefGoogle Scholar
  32. 32.
    Giacobini, E. and Marchi,M. (1981): In: Cholinergic Mechanisms (eds) G. Pepeu and H. Ladinsky, Plenum Press, New York, pp. 1–23.Google Scholar
  33. 33.
    Giacobini, E., Filogamo, G., Giacobini, G. and Vernadakis,A. (eds) (1982): The Aging Brain: Cellular and Molecular Mechanisms of Aging in the Nervous System, Raven Press, New York.Google Scholar
  34. 34.
    Giurgea, C. (1972): Actualites Pharmacol. 25: 115–156.Google Scholar
  35. 35.
    Glisson, S.N., Karczmar, A.G. and Barnes, L. (1974): Neuropharmacology 13: 623–632.CrossRefGoogle Scholar
  36. 36.
    Godel, K. (1931): Monatshefte f. Math. U. Phys. 38: 173–198.Google Scholar
  37. 37.
    Greengard, P. (ed) (1978): Cyclic Nucleotides. Phosphorylated Proteins, and Neuronal Function, Raven Press, New York.Google Scholar
  38. 38.
    Hanin, I., Spiker, D.G., Mallinger, A.G., Kopp, U., Himmelhoch, J.M., Neil, J.F. and Kupfer, D.J. (1981): In: Cholinergic Mechanisms, (eds) G. Pepeu and’H. Ladinsky, Plenum Press, New York, pp. 901–920.Google Scholar
  39. 39.
    Harris, C.M. (1981): Test of memory-enhancing effect of phosphatidyl choline, Ph.D. Thesis, Graduate College of the University of Illinois at the Medical Center, Chicago, Illinois.Google Scholar
  40. 40.
    Hasuo, H., Karczmar, A.G. and Nishimura, T. (1983): Proc. Soc. Neurosci. 9: 925.Google Scholar
  41. 41.
    Heilbronn, E. and Winter, A. (eds) (1970): Drugs and Cholinergic Mechanisms in the CNS, Forsvarfets Forkskningsanstalt, Stockholm, Sweden.Google Scholar
  42. 42.
    Hodges, A. (1983): Alan Turning: The Enigma, Touchstone Brooks, New York.MATHGoogle Scholar
  43. 43.
    Hoffmeister, F. and Mueller, C. (eds) (1979): Brain Function in Old Age, Springer-Verlag, Berlin.CrossRefGoogle Scholar
  44. 44.
    HSkfelt, T., Elfvin, L.G., Schultzber, M., Goldstein, M. and Nilsson, G. (1977): Brain Res. 132: 29–41.CrossRefGoogle Scholar
  45. 45.
    Hökfelt, T., Johansson, O., Ljungdahl, A., Lundberg, J., Schultz-berg, M., Terenius, L., Goldstein, M., Elde, R., Steinbusch, H. and Verhofstad, A. (1979): In: Neurotransmitters (ed) P. Simon, Adv. Pharmacol. Therap., Pergamon Press, Oxford, 2: 131–143.Google Scholar
  46. 46.
    Hokin, M.R. and Hokin, L.E. (1960): Int. Rev. Neurobiol. 2: 99–136.Google Scholar
  47. 47.
    Hoyer, S. (ed) (1982): The Aging Brain, Springer-Verlag, Berlin.CrossRefGoogle Scholar
  48. 48.
    Hudson, C.S., Rash, J.E., Tiedt, T.N. and Albuquerque, E.X. (1978): J. Pharmacol. Exp. Therap. 205: 340–356.Google Scholar
  49. 49.
    Jan, Y.N., Jan, L.Y. and Kuffler, S.W. (1979): Proc. Natl. Acad. Sci. U.S.A. 76: 1501–1505.Google Scholar
  50. 50.
    Jenden, D.J. (ed) (1977): Cholinergic Mechanisms and Psycho-pharmacology, Plenum Press, New York.Google Scholar
  51. 51.
    Johnson, M.K. (1980): Dev. Toxicol. Environ. Sci. 8: 27–38.Google Scholar
  52. 52.
    Karczmar, A.G. (1963a): In: Cholinesterases and Anticholinesterase Agents (ed) G.B. Koelle, Handbch. D. Exper. Pharmakol., Erganzungswk. 15, Springer-Verlag, Berlin, pp. 799–832.Google Scholar
  53. 53.
    Karczmar, A.G. (1963b): In: Cholinesterases and Anticholinesterase Agents (ed) G.B. Koelle, Handbch, D. Exper. Pharmakol., Erganzungswk. 15, Springer-Verlag, Berlin, pp. 179–186.Google Scholar
  54. 54.
    Karczmar, A.G. (1967): In: Physiological Pharmacology (eds) W.S. Root and F.G. Hofman, Academic Press, New York, 3: 163–322.Google Scholar
  55. 55.
    Karczmar, A.G. (1972): In: Brain and Human Behavior (eds) A.G. Karczmar and J.C. Eccles, Springer-Verlag, Berlin, pp. 1–20.CrossRefGoogle Scholar
  56. 56.
    Karczmar, A.G. (1978): In: Neuropsychopharmacology. Proceedings of the 10th Congress, CINP (eds) P. Deniker, C. Radouco-Thomas and A. Villeneuve, Pergamon, Oxford, 1: 581–608.Google Scholar
  57. 57.
    Karczmar, A.G. (1979): In: Nutrition and the Brain (eds) A. Barbeau, J.H. Growdon and R.J. Wurtman, Raven Press, New York, 5: 141–175.Google Scholar
  58. 58.
    Karczmar, A.G. (1979): Drug Therapy 4: 31–42.Google Scholar
  59. 59.
    Karczmar, A.G. (1980): In: Modern Problems in Pharmacopsychiatry (ed) T. Ban, Karger, Basel, pp. 1–76.Google Scholar
  60. 60.
    Karczmar, A.G. (1981a): Psychopharmacol. Bull. 17: 68–70.Google Scholar
  61. 61.
    Karczmar, A.G. (1981b): In: Cholinergic Mechanisms(eds) G. Pepeu and H. Ladinsky, Plenum Press, New York, pp. 853–869.Google Scholar
  62. 62.
    Karczmar, A.G. (1984): Fund. Appl. Toxicol. 4: 1–17.Google Scholar
  63. 63.
    Karczmar, A.G. and Dun, N.J. (1978): In: Psychopharmacology: A Generation of Progress (eds) M.A. Lipton, A. DiMascio and K.F. Killam, Raven Press, New York, pp. 293–305.Google Scholar
  64. 64.
    Karczmar, A.G. and Ohta, Y. (1981): Fund. Appl. Toxicol. 1: 135–142.Google Scholar
  65. 65.
    Karczmar, A.G. and Richardson, D.L. (1985): In: Central Cholinergie Mechanisms and Adaptive Disfunctions (eds) M.M. Singh, D.M. Warburton and H. Lal, Plenum Press, New York, pp. 193–221.CrossRefGoogle Scholar
  66. 66.
    Kindel, G. and Karczmar, A.G. (1981): Fed. Proc. 40: 269.Google Scholar
  67. 67.
    Kindel, G. and Karczmar, A.G. (1982): Fed. Proc. 41: 1232.Google Scholar
  68. 68.
    Koelle, G.B. (1963): In: Cholinesterasesand Anticholinesterase Agents, (ed) G.B. Koelle, Handbch. d. exper. Pharmakol., Erganzungswk 15, Springer-Verlag, Berlin, pp. 187–298.Google Scholar
  69. 69.
    Krnjevic, K. (1974): Physiol. Rev. 54: 418–540.Google Scholar
  70. 70.
    Kuba, K., Albuquerque, E.X., Daly, J. and Barnard, E.A. (1974): J. Pharmacol. Exp. Ther. 189: 499–512.Google Scholar
  71. 71.
    Laskowski, M.B. and Dettbarn, W-D. (1975): J. Pharmacol. Exp. Ther. 194: 351–361.Google Scholar
  72. 72.
    Laskowski, M.B. and Dettbarn, W-D. (1977): Ann. Rev. Pharmacol. Toxicol. 17: 387–409.Google Scholar
  73. 73.
    Libet, B., Kobayashi, H. and Tanaka, T. (1975): Nature 258: 155–157.CrossRefGoogle Scholar
  74. 74.
    Loy, R., Milner, T.A. and Moore, T.Y. (1980): Exper. Neurol. 67: 339–411.CrossRefGoogle Scholar
  75. 75.
    Luria, A.R. (1973): The Working Brain,Basic Books, Inc., Pubis., New York.Google Scholar
  76. 76.
    MacIntosh, F.C. (1977): In: Oholinergic Mechanisms and Psycho-pharmacology (ed) D.J. Jenden, Plenum Press, New York, pp. 297–323.Google Scholar
  77. 77.
    Mantione, C.R., Fisher, A. and Hanin, I. (1981): Science 213: 579–580.CrossRefGoogle Scholar
  78. 78.
    Marchbanks, R.M. (1981): In: Cholinergic Mechanisms (eds) G. Pepeu and H. Ladinsky, Plenum Press, New York, pp. 489–496.Google Scholar
  79. 79.
    McGeer, P.L., Eccles, J.C. and McGeer, E.G. (1978): Molecular Neurobiology of the Mammalian Brain, Plenum Press, New York.CrossRefGoogle Scholar
  80. 80.
    McGeer, P.L., McGeer, E.G. and Peng, J.H. (1984): Life Sciences 34: 2319–2338.CrossRefGoogle Scholar
  81. 81.
    Michell, R.H. (1975): Biochim. Biophys. Acta A15: 81–147.Google Scholar
  82. 82.
    Myers, R.D. (1974): Handbook of Drug and Chemical Stimulation of the Brain, Reinhold, New York.Google Scholar
  83. 83.
    Millington, W.R. and Wurtman, R.J. (1982): J. Neurochem. 38: 1748–1752.CrossRefGoogle Scholar
  84. 84.
    Molgo, J., Lemeignan, M. and Lechat, P. (1975): C.R. hebd. Seanc. Acad. Sci. Paris 281: 1637–1639.Google Scholar
  85. 85.
    Morrow, A.L., Loy, R. and Creese, I. (1980): Proc. Natl. Acad. Sci. U.S.A. 80: 6718–6722.Google Scholar
  86. 86.
    Murait, A.V. (1946): Die Signalubermittlung im Nerven, Verlag Birkhouser, Basel.Google Scholar
  87. 87.
    Nachmansohn, D. (1959): Chemical and Molecular Basis of Nerve Activity, Academic Press, New York.Google Scholar
  88. 88.
    Narahashi, T. (1974): Physiol. Rev. 54: 813–889.Google Scholar
  89. 89.
    Nishimura, T., Hasuo, H. and Karczmar, A.G. (1984): Fed. Proc. 43: 372.Google Scholar
  90. 90.
    Nordberg, A., Adolfsson, R., Marcusson, J. and Winblad, B. (1982): In: The Aging Brain: Cellular and Molecular Mechanisms of Aging in the Nervous System, (eds) E. Giacobini, G. Giacobini, G. Filogamo and A. Vernadakis, Raven Press, New York,pp. 231–245.Google Scholar
  91. 91.
    Ohta, Y. and Karczmar, A.G. (1980): The Pharmacologist 22: 181.Google Scholar
  92. 92.
    Ohta, Y. Karczmar, G.S. and, Karczmar A.G. (1981): Abstracts, Eighth Internl. Congr. Pharmacol., p. 646.Google Scholar
  93. 93.
    Pepeu, G. and Ladinsky,H. (eds) (1981): Cholinergic Mechanisms, Plenum Press, New York.Google Scholar
  94. 94.
    Perry E.K. and Perry, R.H. (1982): In: The Aging Brain, (ed) S. Hoyer, Springer-Verlag, Berlin, pp. 140–145.CrossRefGoogle Scholar
  95. 95.
    Popper, K.R. and Eccles, J.C. (1977): The Self and Its Brain, Springer International, Berlin.CrossRefGoogle Scholar
  96. 96.
    Putney, J.W., Jr., Weiss, S.J., Van de Valle, C.M. and Haddas, R.A. (1980): Nature 28: 345–347.CrossRefGoogle Scholar
  97. 97.
    Raftery, M.A., Bianca, M., Conti-Tronconi, S., Dunn, M.J., Crawford, R.D. and Middlemas, D. (1984): Fund. Appl. Toxicol. 4: S34 - S51.CrossRefGoogle Scholar
  98. 98.
    Richter, J.A. and Gormley, A. (1982): J. Pharmacol. Exper. Therap. 222: 778–785.Google Scholar
  99. 99.
    Rosenberg, P. (1973): J. Pharm. Sci. 62: 1552–1554.Google Scholar
  100. 100.
    Russell, R.W. (1977): In: Cholinergic Mechanisms and Psycho-pharmacology, (ed) D.J. Jenden, Plenum Press, New York, pp. 709–732.Google Scholar
  101. 101.
    Shute, L.L.D. and Lewis, P.R. (1967): Brain 90: 497–520.CrossRefGoogle Scholar
  102. 102.
    Simon, J.R., Atweh, S. and Kuhar, M.J. (1976): J. Neurochem. 26: 909–922.CrossRefGoogle Scholar
  103. 103.
    Singh, M.M. and Kay, S.R. (1976): World J. Psychosynth. 8: 3441.Google Scholar
  104. 104.
    Smith, D.O. (1984): J. Physiol. ( Lond. ) 347: 161–176.Google Scholar
  105. 105.
    Soreq, H., Levin-Sonkin, D. and Razon, N. (in press): The EMBO J.Google Scholar
  106. 106.
    Szerb, J.C. (1977): In: Cholinergic Mechanisms and Psycho-pharmacology (ed) D.J. Jenden, Plenum Press, New York,pp. 49–60.Google Scholar
  107. 107.
    Terry, R.D. and Davies, P. (1980): Ann. Rev. Neurosci. 3: 77–95.Google Scholar
  108. 108.
    Thesleff, S. and Quastel, D.M.J. (1965): Ann. Rev. Pharmacol. 5: 263–284.Google Scholar
  109. 109.
    Thesleff, S. (1980): Neurosci. 5: 1413–1419.CrossRefGoogle Scholar
  110. 110.
    Tucek, S. (1983): In: Enzymes in the Nervous System, (ed) A. Lajtha, Plenum Press, New York, 4: 219–248.Google Scholar
  111. 111.
    VanMeter, W.G., Karczmar, A.G. and Fiscus, R.R. (1978): Arch. Int. Pharmacodyn. 23: 249–260.Google Scholar
  112. 112.
    Waser, P.G. (ed) (1975): Cholinergic Mechanisms, Raven Press, New York.Google Scholar
  113. 113.
    Wecker, L. and Goldberg, A.M. (1981): In: Cholinergic Mechanisms, (eds) G. Pepeu and H. Ladinsky, Plenum Press, New York, pp. 451 461.Google Scholar
  114. 114.
    Whittaker,V.P. (1977): In: Cholinergic Mechanisms and Psychopharmacology, (ed) D.J. Jenden, Plenum Press, New York, pp. 323–345.Google Scholar
  115. 115.
    Witkop, B. and Brossi, A. (1984): In: Natural Products and Drug Development, (eds) P. Krugsgaarch-Larsen, S. Brogger Christensen and H. Kofod, Munksgaard Publs., Copenhagen, pp. 283–300.Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • A. G. Karczmar
    • 1
  1. 1.Department of Pharmacology and TherapeuticsLoyola University Medical CenterMaywoodUSA

Personalised recommendations